Octreotide in intestinal lymphangiectasia: Lack of a clinical response and failure to alter lymphatic function in a guinea pig model

Canadian Journal of Gastroenterology

Volumn 18, Issue 11, 2004, Pages 681-685

  Makhija, S ^a   von der Weid, P Y ^b   Meddings, J ^a,b   Urbanski, S J ^b   Beck, Paul L ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Intestine; Lymphangiectasia; Octreotide; Protein losing enteropathy

Indexed keywords

HISTAMINE; MEDIUM CHAIN TRIACYLGLYCEROL; OCTREOTIDE; SEROTONIN; TETRAHYDROLIPSTATIN;

ADULT; ANIMAL TISSUE; ARTICLE; CASE REPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE COURSE; DRUG MECHANISM; DRUG RESPONSE; FEMALE; GUINEA PIG; HUMAN; INTESTINE LYMPHANGIECTASIA; INTESTINE LYMPHATIC TISSUE; LOW FAT DIET; LYMPH FLOW; LYMPH VESSEL; MEDICAL LITERATURE; MESENTERY LYMPH NODE; NONHUMAN; PARACENTESIS; PRIORITY JOURNAL; SHUNTING; TREATMENT FAILURE;

EID: 10444281598     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/176568     Document Type: Article

References (34)

1. Keberle M, Mork H, Jenett M, Hahn D, Scheurlen M. Computed tomography after lymphangiography in the diagnosis of intestinal lymphangiectasia with protein-losing enteropathy in Noonan's syndrome. Eur Radiol 2000;10:1591-3.
2. Bouhnik Y, Etienney I, Nemeth J, Thevenot T, Lavergne-Slove A, Matuchansky C. Very late onset small intestinal B cell lymphoma associated with primary intestinal lymphangiectasia and diffuse cutaneous warts. Gut 2000;47:296-300.
3. Reifen R, Sherman P. Intestinal lymphangiectasia secondary to neuroblastoma. Can J Gastroenterol 1994;8:49-51.
4. Mine K, Matsubayashi S, Nakai Y, Nakagawa T. Intestinal lymphangiectasia markedly improved with antiplasmin therapy. Gastroenterology 1989;96:1596-9.
5. Heresbach D, Raoul JL, Bretagne JF, Gosselin M. Intestinal lymphangiectasia: Lack of efficacy of antiplasmin therapy? Gastroenterology 1991;100:1152-3.
6. Kuroiwa G, Takayama T, Sato Y, et al. Primary intestinal lymphangiectasia successfully treated with octreotide. J Gastroenterol 2001;36:129-32.
7. Ballinger AB, Farthing MJ. Octreotide in the treatment of intestinal lymphangiectasia. Eur J Gastroenterol Hepatol 1998;10:699-702.
8. Bac DJ, Van Hagen PM, Postema PT, ten Bokum AM, Zondervan PE, van Blankenstein M. Octreotide for protein-losing enteropathy with intestinal lymphangiectasia. Lancet 1995;345:1639.
9. Klingenberg RD, Homann N, Ludwig D. Type I intestinal lymphangiectasia treated successfully with slow-release octreotide. Dig Dis Sci 2003;48:1506-9.
10. Lee HL, Han DS, Kim JB, Jeon YC, Sohn JH, Hahm JS. Successful treatment of protein-losing enteropathy induced by intestinal lymphangiectasia in a liver cirrhosis patient with octreotide: A case report. J Korean Med Sci 2004;19:466-9.
11. Strehl J, Schepke M, Wardelmann E, Caselmann WH, Sauerbruch T. Chronic diarrhea in a 43-year-old patient. Internist (Berl) 2003;44:626-30.
12. Benoit JN, Zawieja DC, Goodman AH, Granger HJ. Characterization of intact mesenteric lymphatic pump and its responsiveness to acute edemagenic stress. Am J Physiol 1989;257:H2059-69.
13. McHale NG, Roddie IC, Thornbury KD. Nervous modulation of spontaneous contractions in bovine mesenteric lymphatics. J Physiol 1980;309:461-72.
14. von der Weid P-Y. Review article: Lymphatic vessel pumping and inflammation - the role of spontaneous constrictions and underlying electrical pacemaker potentials. Aliment Pharmacol Ther 2001;15:1115-29.
15. Wang XY, Wong WC, Ling EA. Studies of the lymphatic vessel-associated neurons in the intestine of the guinea pig. J Anat 1994;185:65-74.
16. Wang XY, Wong WC, Ling EA. Ultrastructural localisation of substance P, vasoactive intestinal peptide and somatostatin immunoreactivities in the submucous plexus of guinea pig ileum. J Anat 1995;186:187-96.
17. Lamberts SW, van der Lely AJ, de Herder WW, Holland LJ. Octreotide. N Engl J Med 1996;334:246-54.
18. 2+ release: A basis for electrical pacemaking in lymphatic smooth muscle. In: Tomita T, Bolton TB, eds. Smooth Muscle Excitation. London: Academic Press, 1996:355-73.
19. von der Weid P-Y, Crowe MJ, van Helden DF. Endothelium-dependent modulation of pacemaking in lymphatic vessels of the guinea pig mesentery. J Physiol 1996;493:563-75.
20. Fox JL, von der Weid PY. Effects of histamine on the contractile and electrical activity in isolated lymphatic vessels of the guinea pig mesentery. Br J Pharmacol 2002;136:1210-8.
21. Chan AK, von der Weid PY. 5-HT decreases contractile and electrical activities in lymphatic vessels of the guinea pig mesentery: Role of 5-HT 7-receptors. Br J Pharmacol 2003;139:243-54.
22. Takahashi H, Imai K. What are the objectives of treatment for intestinal lymphangiectasia? J Gastroenterol 2001;36:137-8.
23. Gashev AA. Physiologic aspects of lymphatic contractile function: Current perspectives. Ann N Y Acad Sci 2002;979:178-87,188-96.
24. Cohen R, Chanson P, Bruckert E, et al. Effects of octreotide on lipid metabolism in acromegaly. Horm Metab Res 1992;24:397-400.
25. McGregor AR, Troughton WD, Donald RA, Espiner EA. Effect of the somatostatin analogue SMS 201-995 on faecal fat excretion in acromegaly. Horm Metab Res 1990;22:55-6.
26. Witt K, Pedersen NT. The long-acting somatostatin analogue SMS 201-995 causes malabsorption. Scand J Gastroenterol 1989;24:1248-52.
27. Moller N, Petrany G, Cassidy D, Sheldon WL, Johnston DG, Laker MF. Effects of the somatostatin analogue SMS 201-995 (sandostatin) on mouth-to-caecum transit time and absorption of fat and carbohydrates in normal man. Clin Sci (Lond) 1988;75:345-50.
28. Shiratori K, Watanabe S, Takeuchi T. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats. Pancreas 1991;6:23-30.
29. Maes BD, Ghoos YF, Geypens BJ, Hiele MI, Rutgeerts PJ. Influence of octreotide on the gastric emptying of solids and liquids in normal healthy subjects. Aliment Pharmacol Ther 1995;9:11-8.
30. Hurst RD, Ballantyne GH, Modlin IM. Octreotide inhibition of serotonin-induced ileal chloride secretion. J Surg Res 1995;59:631-5.
31. Wangberg B, Nilsson O, Theodorsson E, Dahlstrom A, Ahlman H. The effect of a somatostatin analogue on the release of hormones from human midgut carcinoid tumour cells. Br J Cancer 1991;64:23-8.
32. McHale NG, Thornbury KD, Hollywood MA. 5-HT inhibits spontaneous contractility of isolated sheep mesenteric lymphatics via activation of 5-HT(4) receptors. Microvasc Res 2000;60:261-8.
33. Wiest R, Tsai MH, Groszmann RJ. Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats. Gastroenterology 2001;120:975-83.
34. Gashev AA, Davis MJ, Zawieja DC. Inhibition of the active lymph pump by flow in rat mesenteric lymphatics and thoracic duct. J Physiol 2002;540:1023-37.